← Back to QNTM

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2025Filed 06/11/2025Jun 2025Filed 07/08/2025Mar 2025Filed 16/06/2025Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 16/06/2025Sep 2023Filed 12/11/2024
−$4.7−$9.8−$8.7−$4−$3.4−$2.1−$1.1

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.